[Retracted] Analysis of the Correlation of Basic Fibroblast Growth Factor in Serum of Patients with Diffuse Large B-Cell Lymphoma with Clinicopathological Efficacy and International Prognostic Index

Table 3

Comparison of serum bFGF levels and IPI scores in patients with different prognoses ( ± s).

Group	Serum bFGF (ng/mL)		IPI score (score)
	Before the treatment	After the treatment	Before the treatment	After the treatment
DLBCL patients improved group (n = 73)	21.07 ± 1.62	16.12 ± 1.59	3.48 ± 0.51	1.81 ± 0.24
DLBCL patients deteriorated group (n = 42)	25.68 ± 2.25	21.74 ± 2.18	3.97 ± 0.55	2.86 ± 0.36
T	−12.707	−15.890	−4.820	−18.737
	＜0.001	＜0.001	＜0.001	＜0.001